General Updates

Date: June 19, 2026 The Manager The Secretary Listing Department Listing Department National Stock Exchange of India BSE Limited Limited 1st Floor, Phiroze Jeejeebhoy Towers, Exchange Plaza, C-1, Block G, Dalal Street, Bandra Kurla Complex, Bandra (East) Mumbai 400 001 Mumbai 400 051 BSE Scrip Code: 543308 Maharashtra, India NSE Symbol: KIMS Sub: Qualified institutions placement of equity shares of face value ₹ 2 each (the “Equity Shares”) by Krishna Institute of Medical Sciences Limited (the “Company”) under the provisions of Chapter VI of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended (the “SEBI ICDR Regulations”), and Sections 42 and 62(1)(c) of the Companies Act, 2013, as amended, including the rules made thereunder (the “Issue”). Dear Madam/ Sir, Further to our letter dated June 19, 2026 intimating you about the meeting of the Finance & Investment Committee in respect of the Issue, we wish to inform you that the Finance & Investment Committee at its meeting held today, i.e., June 19, 2026 has, inter alia, passed the following resolutions: a. approved and declared the closure of the issue period for the Issue today, i.e., June 19, 2026, pursuant to the receipt of application forms and the funds in the escrow account from the eligible qualified institutional buyers in accordance with the terms of the Issue; b. determined and approved the allocation of 19,867,549 Equity Shares to be allotted to eligible qualified institutional buyers at a price of ₹ 755 per Equity Share, including a premium of ₹ 753 per Equity Share, which takes into account a discount of ₹ 16.73 per Equity Share (2.17% of the floor price) on the floor price, upon closure of the Issue, as permitted in terms of Regulation 176(1) of Chapter VI of the SEBI ICDR Regulations; c. approved and adopted the placement document dated June 19, 2026 in connection with the Issue. Copy of the same is being also made available on the website of the Company at www.kimshospitals.com/investors; d. approved and finalized the confirmation of allocation note to be sent to the eligible qualified institutional buyers, intimating them of allocation of Equity Shares pursuant to the Issue; and e. approved issuance of refund intimation letter to the bidders who are entitled to receive the refund amount, if any. A certified to be true copy of the resolution for the Issue closure passed by the Finance & Investment Committee is enclosed for your information and records. The meeting of the Finance & Investment Committee commenced at 6:15 PM. and concluded at 7:30 P.M. In this relation we are filing the placement document dated June 19, 2026 with your office. The Issue was opened on June 16, 2026 and the same was intimated to you pursuant to our letter dated June 16, 2026. We request you to take the above on record and treat the same as compliance under the applicable provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. Thanking you, For Krishna Institute of Medical Sciences Limited Nagajayanthi Juttur Raghavendra Das Company Secretary & Compliance office